IRIS
AIUTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.237
EU - Europa 2.276
AS - Asia 1.654
SA - Sud America 295
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 15.493
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.187
DE - Germania 866
SG - Singapore 766
CN - Cina 393
IT - Italia 246
BR - Brasile 235
HK - Hong Kong 233
UA - Ucraina 218
GB - Regno Unito 215
RU - Federazione Russa 187
IE - Irlanda 181
SE - Svezia 87
VN - Vietnam 77
FI - Finlandia 76
FR - Francia 66
KR - Corea 43
CA - Canada 29
AR - Argentina 27
ES - Italia 24
IN - India 24
AT - Austria 22
ID - Indonesia 21
NL - Olanda 21
BE - Belgio 18
MX - Messico 18
TR - Turchia 16
PL - Polonia 15
JP - Giappone 14
EC - Ecuador 12
ZA - Sudafrica 12
BD - Bangladesh 10
IR - Iran 8
PE - Perù 7
AE - Emirati Arabi Uniti 6
IQ - Iraq 6
KG - Kirghizistan 6
LT - Lituania 6
UZ - Uzbekistan 6
CL - Cile 5
SA - Arabia Saudita 5
CH - Svizzera 4
EU - Europa 4
CZ - Repubblica Ceca 3
GR - Grecia 3
HU - Ungheria 3
IL - Israele 3
MA - Marocco 3
PH - Filippine 3
PK - Pakistan 3
PY - Paraguay 3
RO - Romania 3
VE - Venezuela 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
GE - Georgia 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
RS - Serbia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AW - Aruba 1
CG - Congo 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
TW - Taiwan 1
Totale 15.493
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.527
Wilmington 2.524
Houston 2.397
Fairfield 620
Singapore 444
Ann Arbor 389
Ashburn 336
Chandler 258
Seattle 238
Hong Kong 229
Cambridge 192
Jacksonville 192
Beijing 183
Dublin 168
Medford 124
Santa Clara 98
Dearborn 89
Rome 84
Lawrence 51
Buffalo 47
New York 44
Los Angeles 41
Menlo Park 41
Munich 39
The Dalles 36
Zhengzhou 33
San Diego 29
São Paulo 24
Nuremberg 23
Helsinki 22
Mülheim 22
Chicago 21
Dallas 21
Council Bluffs 20
Ho Chi Minh City 19
Falls Church 18
London 18
Milan 17
Brussels 16
Moscow 16
Phoenix 16
Boardman 15
Hanoi 15
Nanjing 15
Chongqing 14
Hefei 14
Redwood City 14
Jakarta 13
Frankfurt am Main 12
Norwalk 12
San Mateo 12
Shanghai 12
Brooklyn 11
Toronto 11
University Park 11
Vienna 11
Barcelona 10
Dong Ket 9
Montreal 9
Orem 9
Stockholm 9
Amsterdam 8
Boston 8
Warsaw 8
Belo Horizonte 7
Johannesburg 7
Mexico City 7
Mountain View 7
Poplar 7
Redondo Beach 7
Rio de Janeiro 7
Tokyo 7
Verona 7
Ankara 6
Denver 6
Elk Grove Village 6
Engelhard 6
Jinan 6
Kunming 6
Manchester 6
Turku 6
Atlanta 5
Buenos Aires 5
Chennai 5
Florence 5
Hangzhou 5
Lappeenranta 5
Baghdad 4
Bexley 4
Center 4
Columbus 4
Guangzhou 4
Guayaquil 4
Kilburn 4
Lima 4
Redmond 4
Salvador 4
Seoul 4
St. George 4
Vancouver 4
Totale 12.181
Salva come PNG Salva come JPEG
Nome #
Gene therapy for immunodeficiency due to adenosine deaminase deficiency 502
Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency 496
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome. 485
Clinical features and follow-up in patients with 22q11.2 deletion syndrome 475
Chronic Granulomatous Disease Presenting with Salmonella Brain Abscesses. 468
Early-onset monocyte-B-natural killer-dendritic cells' deficiency successfully treated with hematopoietic stem cell transplantation. 459
Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis 454
The Quality of Life of Children and Adolescents with X-Linked Agammaglobulinemia 439
Etiology, clinical outcome, and laboratory features in children with neutropenia: analysis of 104 cases 437
In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency. 436
Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID 434
. Early-onset monocyte-B-natural killer-dendritic cells’ deficiency successfully treated with hematopoietic stem cell transaplantation 434
Autoimmunity and regulatory T cells in 22q11.2 deletion syndrome patients 430
The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function 423
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency 413
Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) 407
Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease 403
Successful treatment with percutaneous transhepatic alcoholization of a liver abscess in a child with chronic granulomatous disease 402
Long-Term Safety and Efficacy of Gene Therapyfor Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency 399
Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency 352
null 316
Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies. Front Immunol. 2019 Apr 11;10:316. doi: 10.3389/fimmu.2019.00316. eCollection 2019. Erratum in: Front Immunol. 2019 May 31;10:1184. 299
Targeted NGS platforms for genetic screening and gene discovery in primary immunodeficiencies 294
JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene 221
First Case of Patient With Two Homozygous Mutations in MYD88 and CARD9 Genes Presenting With Pyogenic Bacterial Infections, Elevated IgE, and Persistent EBV Viremia 210
The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment 204
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy 195
Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: Analysis of function and distribution in lymphoid organs 193
Impaired X-CGD T cell compartment is gp91phox-NADPH oxidase independent 192
ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency 187
How I treat ADA deficiency 181
Comprehensive genomic access to vector integration in clinical gene therapy. 179
Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy 172
Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID 169
Health-Related Quality of Life and Emotional Difficulties in Chronic Granulomatous Disease: Data on Adult and Pediatric Patients from Italian Network for Primary Immunodeficiency (IPINet) 168
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 167
Large Deletion of MAGT1 Gene in a Patient with Classic Kaposi Sarcoma, CD4 Lymphopenia, and EBV Infection 161
Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy 160
Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency 158
Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID 157
Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. 155
Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models 149
Gene therapy for adenosine deaminase deficiency. 144
Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell. 142
Dendritic cell functional improvement in a preclinical model of lentiviral-mediated gene therapy for Wiskott-Aldrich syndrome 142
Gene therapy for primary immunodeficiencies: Part 1 142
Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity 140
Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency. 133
Gene therapy for primary immunodeficiencies: Part 2 129
Retroviral integrations in gene therapy trials 129
New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapy. 128
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999-2019) 114
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 105
Ten years of gene therapy for primary immuno deficiencies 104
Severe Toxoplasma gondii infection in a member of a NFKB2-deficient family with T and B cell dysfunction 88
SARS-CoV-2 infection and treatment in a cohort of patients with inborn errors of immunity 82
Autoantibodies against type I IFNs in patients with life-threatening COVID-19 78
Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity 72
SARS-CoV-2-related MIS-C: a key to the viral and genetic causes of Kawasaki disease? 66
The Inborn Errors of Immunity—Virtual Consultation System Platform in Service for the Italian Primary Immunodeficiency Network: Results from the Validation Phase 64
Natural history of Ras-associated autoimmune leukoproliferative disorder: A 20-year follow-up of a NRAS-mutated patient excluding a malignant progression 63
Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait? 61
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 60
A prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis 58
Harnessing type I IFN immunity against SARS-CoV-2 with early administration of IFN-β 58
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 52
Consensus of the Italian Primary Immunodeficiency Network on the use and interpretation of genetic testing for the diagnosis of inborn errors of immunity (IEI) 50
Studying severe long COVID to understand post-infectious disorders beyond COVID-19 46
From your nose to your toes: a review of severe acute respiratory syndrome Coronavirus 2 pandemic‒associated pernio 40
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity 40
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection 39
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 36
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 33
Totale 15.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.773
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.067 0 0 0 0 0 217 281 237 96 84 107 45
2021/2022660 22 70 28 35 42 48 31 46 77 46 37 178
2022/2023744 83 57 28 82 56 182 71 42 62 10 50 21
2023/2024281 32 26 20 14 35 61 13 19 12 0 7 42
2024/20251.554 53 358 157 93 64 148 158 96 122 101 125 79
2025/20261.308 207 160 311 261 254 115 0 0 0 0 0 0
Totale 15.673